Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis
Yang Pan, Liang Wang, Zhaomin Feng, et al.
The Lancet (2023) Vol. 401, Iss. 10377, pp. 664-672
Open Access | Times Cited: 168

Showing 26-50 of 168 citing articles:

Humoral immune response characteristics of vulnerable populations against SARS-CoV-2 strains EG.5 and JN.1 after infection with strains BA.5 and XBB
Huan Zhang, Shi Ouyang, Yunhui Qu, et al.
Archives of Virology (2025) Vol. 170, Iss. 4
Closed Access
Effects of public-health measures for zeroing out different SARS-CoV-2 variants
Yong Ge, Xilin Wu, Wenbin Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Dynamics of anti-SARS-CoV-2 IgG antibody responses following breakthrough infection and the predicted protective efficacy: a longitudinal community-based population study in China
Xiaolong Yan, Xin Zhao, Yin Du, et al.
International Journal of Infectious Diseases (2024) Vol. 145, pp. 107075-107075
Open Access | Times Cited: 4
MALDI‐TOF MS analysis of nasal swabs for the characterization of patients infected with SARS‐CoV‐2 Omicron
Rui Song, Dandan Li, Xiaohua Hao, et al.
View (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 4
Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera
Kun Xu, Yaling An, Xueyuan Liu, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Single-cell transcriptome atlas of peripheral immune features to Omicron breakthrough infection under booster vaccination strategies
Yuwei Zhang, Shanshan Han, Qingshuai Sun, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai
Bo Zheng, Bronner P. Gonçalves, Pengfei Deng, et al.
eLife (2025) Vol. 13
Open Access
Using an influenza surveillance system to estimate the number of SARS-CoV-2 infections in Beijing, China, weeks 2 to 6 2023
Li Zhang, Yi Zhang, Wei Duan, et al.
Eurosurveillance (2023) Vol. 28, Iss. 11
Open Access | Times Cited: 10
Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection
Lianpan Dai, Huixin Duan, Xueyuan Liu, et al.
The Lancet (2023) Vol. 402, Iss. 10403, pp. 687-689
Closed Access | Times Cited: 10
Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis
Han Du, Zhongtao Du, Liang Wang, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2024) Vol. 51, Iss. 6, pp. 608-616
Closed Access | Times Cited: 3
Broad-spectrum Delta-BA.2 tandem-fused heterodimer mRNA vaccine delivered by lipopolyplex
Pei Du, Lei Huang, Yi Fang, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 4, pp. e1012116-e1012116
Open Access | Times Cited: 3
Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study
Siyue Jia, Zundong Yin, Hongxing Pan, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
A Tip Optofluidic Immunoassay System for COVID-19 Immuno-protection Evaluation Using Fingertip Blood
Ruihan Li, Binmao Zhang, Li Hao, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection
Xiaolin Jiang, Xuedong Song, Chao Shi, et al.
Cell Reports (2024) Vol. 43, Iss. 7, pp. 114387-114387
Open Access | Times Cited: 3
Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants
Xiaohua Gong, Ling Peng, Fuxiang Wang, et al.
Journal of Infection (2024) Vol. 89, Iss. 2, pp. 106208-106208
Open Access | Times Cited: 3
Rapid and extensive SARS-CoV-2 Omicron variant infection wave revealed by wastewater surveillance in Shenzhen following the lifting of a strict COVID-19 strategy
Yinghui Li, Du Chen, Ziquan Lv, et al.
The Science of The Total Environment (2024) Vol. 949, pp. 175235-175235
Closed Access | Times Cited: 3
Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022–2023) following a pivotal shift in the pandemic
Zhencui Li, Pei Hu, Qu Lin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
A Comparison of Clinical Characteristics of Infections with SARS-CoV-2 Omicron Subvariants BF.7.14 and BA.5.2.48 — China, October–December 2022
Da Huo, Tong Yu, Jianfa Shen, et al.
China CDC Weekly (2023) Vol. 5, Iss. 23, pp. 511-515
Open Access | Times Cited: 9
Humoral immune response characteristics of the elderly, children and pregnant women after XBB infection
Fen Ouyang, Huan Zhang, Yushan Jiang, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. e96-e99
Closed Access | Times Cited: 8
The second dose of COVID-19 vaccine booster hesitancy among health care workers in China: A multicenter cross-sectional study
Ling Zhang, Yijin Wu, Shu Jing, et al.
American Journal of Infection Control (2023) Vol. 52, Iss. 5, pp. 525-532
Closed Access | Times Cited: 8
Omicron breakthrough infections in wild‐type SARS‐CoV‐2 vaccinees elicit high levels of neutralizing antibodies against pangolin coronavirus GX_P2V
Shanshan Lu, Shengdong Luo, Bingke Bai, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 7
SARS-CoV-2–specific antibody and T-cell immunity in convalescents after infection wave in Beijing in late 2022
Xuejiao Guan, Qi Huang, Mei Dong, et al.
Journal of Infection (2023) Vol. 87, Iss. 5, pp. 413-419
Closed Access | Times Cited: 7
AntiViralDL: Computational Antiviral Drug Repurposing Using Graph Neural Network and Self-Supervised Learning
Pan Zhang, Xiaowen Hu, Guangdi Li, et al.
IEEE Journal of Biomedical and Health Informatics (2023) Vol. 28, Iss. 1, pp. 548-556
Closed Access | Times Cited: 7
Interpreting COVID-19 data from China: a call for caution – Authors' reply
Liang Wang, Quanyi Wang, George F. Gao
The Lancet (2024) Vol. 403, Iss. 10422, pp. 144-145
Open Access | Times Cited: 2

Scroll to top